Skip to content

To know the efficacy between Vasaghruta and Kulattadi Kashaya in Asthma

A Controlled Double Arm Open Labelled Clinical Trial to Evaluate the Efficacy of Vrusha Ghruta and Kulatthadi Kashaya in the Management of Tamaka Shwasa vis a vis Bronchial Asthma - NILL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087304
Enrollment
40
Registered
2025-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

None listed

Sponsors

DR NAYANA D R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Subjects fulfilling the diagnostic criteria of Tamaka Swasa. 2)Subjects having peak expiratory flow rate of greter than 50percent of predicted value of Peak Expiratory Flow Rate chart. 3)Subjects within the age group of 18 to 60 years. 4) Both fresh and treated cases

Exclusion criteria

Exclusion criteria: 1) Acute condition of Bronchial Asthma, Status Asthmaticus. 2) Subjects suffering from associated diseases like Tuberculosis, pneumonia,Cardiac asthma,Uncontrolled Diabetes mellitus FBS 180ml by dl,Uncontrolled Hypertension BP 160by100mmhg 3) Subjects having peak expiratory flow rate of lessthan 50percent of predicted value of Peak Expiratory Flow Rate chart. 4)Subjects who are on corticosteroids. 5)Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
1)Asthma control questionaire value less than 1.5 Timepoint: 0th day, 8th day, 31st day.

Secondary

MeasureTime frame
Symptomatically relief to the patientTimepoint: 0th day 8th day and 31st day

Countries

India

Contacts

Public ContactDR Nayana D R

Government Ayurveda Medical College and Hospital, Mysuru

drsanjaygowda@gmail.com9986083244

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026